Search

Search Results

• 

  Janus kinase inhibitors: between prescription authorization and reimbursability

  F.R. Spinelli, F. Conti, R. Caporali, F. Iannone, F. Cacciapaglia, on behalf of the Steering Committee of the Italian Society of Rheumatology

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1627

  1403

  PDF: 360

• PO:13:188 | Menstrual alterations among women with rheumatoid arthritis: a comparative study across treatment modalities with focus on JAK inhibitors Angelica Napoletano¹, Francesca Arezzo², Marco Fornaro¹, Giuseppe Lopalco¹, Gennaro Cormio², Vincenzo Venerito¹, Florenzo Iannone¹. | ¹University of Bari, Rheumatology Unit Department of Precision and Regenerative Medicine, Jonica Area, Bari; ²Gynecologic Oncology, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2029

  220
• 

  Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

  Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

  13-01-2025

  https://doi.org/10.4081/reumatismo.2025.1718

  1854

  PDF: 252

  SUPPLEMENTARY MATERIAL: 153
• 

  Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

  Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

  29-01-2025

  https://doi.org/10.4081/reumatismo.2025.1754

  2092

  PDF: 387

  SUPPLEMENTARY MATERIAL: 159
• 

  PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors

  Cristina Garufi, Silvia Mancuso, Fulvia Ceccarelli, Letizia Caruso, Cristiano Alessandri, Manuela Di Franco, Roberta Priori, Valeria Riccieri, Rossana Scrivo, Simona Truglia, Fabrizio Conti, Francesca Romana Spinelli

  05-11-2024

  https://doi.org/10.4081/reumatismo.2024.1725

  2590

  PDF: 364

• CO:10:3 | Clinical response to JAK inhibitors or non-TNFi-targeted biologicals according to synovial tissue characteristics in patients with difficult-to-treat rheumatoid arthritis Mariangela Salvato¹, Alessandro Giollo¹, Francesca Frizzera¹, Kiren Khalid¹, Lorenzo Di Luozzo¹, Maria Capita¹, Marianna Tamussin¹, Carlo Garaffoni², Marny Fedrigo³, Annalisa Angelini³, Ettore Silvagni², Andrea Doria¹. | ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova; ²Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna; ³Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.1992

  119
• 

  The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease

  Ennio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, Carla Felice, Fabio Massimo Perrotta, Vincenzo Venerito, Sergio Del Vescovo, Roberta Ramonda, Giulia Cassone, Fabiola Atzeni, Roberto Caporali, Fabrizio Conti, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Ennio Giulio Favalli

  11-11-2024

  https://doi.org/10.4081/reumatismo.2024.1688

  2090

  PDF: 525
• 

  Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

  Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

  28-10-2024

  https://doi.org/10.4081/reumatismo.2024.1796

  2025

  PDF: 431
• 

  Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review

  Carlo Perricone, Roberto Dal Pozzolo, Giacomo Cafaro, Santina Calvacchi, Lorenza Bruno, Francesco Tromby, Anna Colangelo, Roberto Gerli, Elena Bartoloni

  25-10-2024

  https://doi.org/10.4081/reumatismo.2024.1685

  2339

  PDF: 682

• PO:04:051 | Application of REMS in the assessment of fragility score and bone mineral density in axial spondyloarthritis and psoriatic arthritis with axial involvement Silvia Valentini¹, Stefano Gentileschi¹, Pamela Bernardini², Jurgen Sota¹, Caterina Baldi¹, Sara Torracchi², Daniela Melchiorre², Sabrina Aliberti², Emilio D'Ignazio¹, Carla Caffarelli³, Luca Cantarini¹, Serena Guiducci², Bruno Frediani¹ | ¹UOC Reumatologia, Dipartimento di Scienze mediche, chirurgiche e neuroscienze, Università degli Studi di Siena; ²SOD Reumatologia, Dipartimento di Medicina Sperimentale e clinica, Università degli studi di Firenze, AOU Careggi; ³UOC Medicina Interna e della Complessità, Dipartimento di Scienze Mediche, chirurgiche e neuroscienze, Università degli Studi di Siena, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2129

  106